AP2010005274A0 - Pharmaceutical composition containing a zeo-lite/algae or zeo-lite/emulsion combination for the treatment of AIDS - Google Patents

Pharmaceutical composition containing a zeo-lite/algae or zeo-lite/emulsion combination for the treatment of AIDS

Info

Publication number
AP2010005274A0
AP2010005274A0 AP2010005274A AP2010005274A AP2010005274A0 AP 2010005274 A0 AP2010005274 A0 AP 2010005274A0 AP 2010005274 A AP2010005274 A AP 2010005274A AP 2010005274 A AP2010005274 A AP 2010005274A AP 2010005274 A0 AP2010005274 A0 AP 2010005274A0
Authority
AP
ARIPO
Prior art keywords
zeo
lite
algae
aids
treatment
Prior art date
Application number
AP2010005274A
Inventor
Axel Dr Siegner
Original Assignee
Neopharmacie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharmacie Gmbh filed Critical Neopharmacie Gmbh
Publication of AP2010005274A0 publication Critical patent/AP2010005274A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
AP2010005274A 2007-11-23 2008-11-21 Pharmaceutical composition containing a zeo-lite/algae or zeo-lite/emulsion combination for the treatment of AIDS AP2010005274A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007056424A DE102007056424A1 (en) 2007-11-23 2007-11-23 Pharmaceutical composition containing an oil / water emulsion
PCT/EP2008/066033 WO2009065947A2 (en) 2007-11-23 2008-11-21 Pharmaceutical composition containing a zeolite/algae or zeolite/emulsion combination for the treatment of aids

Publications (1)

Publication Number Publication Date
AP2010005274A0 true AP2010005274A0 (en) 2010-06-30

Family

ID=40457343

Family Applications (2)

Application Number Title Priority Date Filing Date
AP2010005274A AP2010005274A0 (en) 2007-11-23 2008-11-21 Pharmaceutical composition containing a zeo-lite/algae or zeo-lite/emulsion combination for the treatment of AIDS
AP2010005275A AP2010005275A0 (en) 2007-11-23 2008-11-21 Pharmaceutical kit consisting of an oil-in water emulsion and a solid composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
AP2010005275A AP2010005275A0 (en) 2007-11-23 2008-11-21 Pharmaceutical kit consisting of an oil-in water emulsion and a solid composition

Country Status (6)

Country Link
EP (1) EP2259789A2 (en)
AP (2) AP2010005274A0 (en)
DE (1) DE102007056424A1 (en)
RU (2) RU2496506C2 (en)
WO (2) WO2009065946A2 (en)
ZA (2) ZA201003573B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2545788A1 (en) * 2011-07-13 2013-01-16 Martin Hulliger Dietary multi-component system
RU2708161C1 (en) * 2019-04-16 2019-12-05 Иван Павлович Уваров Fodder complex biologically active additive for animals and birds

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
AU3082699A (en) * 1998-03-16 1999-10-11 Procter & Gamble Company, The Method of treating skin irritation
DE19940011B4 (en) * 1999-08-24 2009-04-02 Schütte/Reichel GbR (vertretungsberechtigte Gesellschafter: Irene Schütte Alginate preparation and their use
US20060122082A1 (en) * 2000-02-17 2006-06-08 Leonard Paul Foam/spray producing compositions and dispensing system therefor
US20030216364A1 (en) * 2001-08-13 2003-11-20 Johnson Keith Arthur Dermatological Formulation
US20050058672A1 (en) * 2003-09-14 2005-03-17 Bioderm Research Baby Care Skin Protectant Compositions for Diaper Rash
MXPA05011208A (en) * 2003-04-24 2005-12-14 Galderma Sa Topical formulation of ivermectin for the treatment of dermatological conditions.
US20040253323A1 (en) * 2003-06-11 2004-12-16 Giles Brian C. Ionic cancer therapy and methods for using same in the treatment of tumors and metastasis
US7485451B2 (en) * 2004-11-18 2009-02-03 Regents Of The University Of California Storage stable compositions of biological materials
DE102005009515A1 (en) * 2005-02-25 2006-09-07 Exner, Heinrich, Dr. A process for preparing a preparation of a DMSO-containing solid silicone oil emulsion for binding reactive oxygen compounds in the body of humans and animals
US20070031512A1 (en) * 2005-08-03 2007-02-08 Amcol International Corporation Virus-interacting layered phyllosilicates and methods of inactivating viruses
WO2007032727A1 (en) * 2005-09-16 2007-03-22 Dsm Ip Assets B.V. Particulate lipid pharmaceutical composition
CN101360424B (en) * 2005-11-22 2013-05-15 雀巢技术公司 Easily dispersible lipidic phase
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
GB0602528D0 (en) * 2006-02-08 2006-03-22 Ici Plc Emulsification systems, emulsions and wet wipes containing such emulsions
WO2007098186A2 (en) * 2006-02-22 2007-08-30 Novavax, Inc. Adjuvant and vaccine compositions
CA2645080A1 (en) * 2006-03-07 2007-09-13 Novavax,Inc. Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same

Also Published As

Publication number Publication date
WO2009065947A3 (en) 2009-11-19
WO2009065947A2 (en) 2009-05-28
WO2009065946A3 (en) 2009-07-16
ZA201003573B (en) 2011-04-28
AP2010005275A0 (en) 2010-06-30
RU2010125503A (en) 2011-12-27
WO2009065946A2 (en) 2009-05-28
EP2259789A2 (en) 2010-12-15
DE102007056424A1 (en) 2009-05-28
RU2010125505A (en) 2011-12-27
ZA201003574B (en) 2011-02-23
RU2496506C2 (en) 2013-10-27

Similar Documents

Publication Publication Date Title
IL195571A0 (en) Compounds for the treatment of periodontal disease
HK1131141A1 (en) Imidazolothiazole compounds for the treatment of disease
EP2040721A4 (en) Medicinal compositions containing honey
GB2454797B (en) Treatment of wastewater
EP1976377A4 (en) Compounds for the treatment of metabolic disorders
EP2124878A4 (en) Increased effectiveness of allylamine drug compounds
EP1983972A4 (en) Compounds for the treatment of metabolic disorders
PL2078066T3 (en) Biocide for well stimulation
EP2019673A4 (en) Compounds for the treatment of metabolic disorders
IL192852A0 (en) Compounds for the treatment of metabolic disorders
ZA200905468B (en) Therapeutical uses of eslicarbazepine
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
ZA200806505B (en) Treatment of HIV
IL192851A0 (en) Compounds for the treatment of metabolic disorders
AP2010005274A0 (en) Pharmaceutical composition containing a zeo-lite/algae or zeo-lite/emulsion combination for the treatment of AIDS
GB0723100D0 (en) Treatment of HFnEF
EP2026659A4 (en) Compounds for the treatment of metabolic disorders
IL193819A0 (en) Concentrate of chikungunya-specific immunoglobulins as medicine
HK1120034A1 (en) Pharmaceuticals for treating or preventing oral diseases
GB0602857D0 (en) The treatment of sialorrhoea
ZA200807156B (en) Liquid treatment composition
IL192982A0 (en) Compounds for the treatment of metabolic disorders
GB0602858D0 (en) The treatment of sialorrhoea
GB0602855D0 (en) The Treatment Of Sialorrhoea
IL176497A0 (en) Separating arrangement for treatment of fluids